Yoji Honda
Hiroshima, 7310293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.
Journal: Cancers
Published: August 02, 2022
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
Journal: Cancers
Published: December 12, 2021
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Journal: Oncology
Published: February 15, 2021
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
Journal: Oncology
Published: December 29, 2020
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
Journal: Oncology
Published: November 30, 2020
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Journal: Journal of gastroenterology and hepatology
Published: February 02, 2018
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.
Journal: Journal of medical virology
Published: February 06, 2017
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.
Journal: Journal of gastroenterology and hepatology
Published: August 07, 2016
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Journal: Anticancer research
Published: April 28, 2016
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirin.
Journal: Antimicrobial agents and chemotherapy
Published: January 29, 2014
Last Updated: 09/26/2026